Bioengine Capital Inc.'s Form 4 filing
Windtree Therapeutics Inc (WINT) · filed Jan 10, 2022
- Accession no.
- 0001213900-22-001390
- Filed
- Jan 10, 2022
- Trade date
- May 20, 2020-Dec 30, 2021
- Filing delay
- 600 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market purchases total $400.0K. Open-market sales total $1.98M. It was filed 600 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bioengine Capital Inc.CIK 0001770197 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2020 | Common Stock | JOtherDisposed | −3,551,750 | $0.00 | $0 | 1,183,916 | Direct | |
| May 20, 2020 | Common Stock | PPurchaseAcquired | +55,172 | $7.25 | +$399,997 | 1,239,088 | Direct | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −1,239,088 | $1.60 | −$1,982,540.8 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2020 | Common Stock | JOtherDisposed | −384,824 | $0.00 | $0 | 0 | Direct | |
| May 20, 2020 | Common Stock | JOtherDisposed | −249,004 | $0.00 | $0 | 249,004 | Direct | |
| May 20, 2020 | Common Stock | PPurchaseAcquired | +55,172 | $0.00 | $0 | 55,172 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.